Publikacje
- Szubert M, Gabriel I, Rycerz A, Golinska M, Wilczyński JR. MicroRNA Expression Profile in Endometriosis and Endometriosis-Associated Ovarian Cancer-Systematic Review. Cells. 2026 Feb 20;15(4):374. doi: 10.3390/cells15040374
- Golinska M, Rycerz A, Sobczak M, Chrzanowski J, Stawiski K, Fendler W. Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis. Front Immunol. 2025 Jul 8;16:1619434. doi: 10.3389/fimmu.2025.1619434.
- Golinska M, Wolyniak M, Kulesza P, Fendler W. Neuroinflammation is responsible for pain in endometriosis -Targeting the JAK-STAT Pathway and Mast Cell Activation. Front Immunol. doi: 10.3389/fimmu.2025.1621178
- Lefebvre TL, Oraiopoulou ME, Bunce EV, Else TR, Wright LC, Golinska M, Hacker L, Brodie C, Kupczak S, Cheng Y, Young L, Sweeney PW, Bohndiek SE. Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging. Adv Sci. 2026;13:e09268. doi: 10.1002/advs.202509268
Granty
- MSCA POLONEZ BIS 3 – Narodowe Centrum Nauki / EU „Identyfikacja markerów angiogenezy i markerów metabolicznych w endometriozie i powiązanym z nią nabłonkowym nowotworze jajnika przy użyciu obrazowania fotoakustycznego i eksploracji danych (ENDOVO)” 1 208 983 PLN Kierownik: dr Monika Anna Golińska
- SONATA 20 – Narodowe Centrum Nauki „Rola ścieżki JAK/STAT3 i komórek tucznych w przewlekłym bólu związanym z endometriozą” 1 998 486 PLN Kierownik: dr Monika Anna Golińska
- PRELUDIUM 24 – Narodowe Centrum Nauki “The JAK/STAT pathway as a molecular driver of endometriosis development: therapeutic potential of JAK inhibition” 209 800 PLN Kierownik: lek med. Aleksander Rycerz
Konferencje
- European Endometriosis Congress, Italy – Dissecting Endometriosis Subtypes: MAPK, CDK, and CD47 Pathways as Therapeutic Targets (talk, Apr 2026)
- European Endometriosis Congress, Italy – Dysregulated Gene Expression and LEFTY1 Delocalization in the Eutopic Endometrium of Women with Endometriosis: Implications for Infertility (poster, Apr 2026)
- Society for Reproductive Investigation Annual Conference, USA – CD47 and CDK2 Pathways as Therapeutic Targets in Endometriosis Subtypes: Insights from Transcriptomic Meta-Analysis (talk, Mar 2026)
- World Congress of Endometriosis, Australia – Transcriptomic Profiling of Adenomyosis Highlights the Role of Extracellular Matrix Remodeling, Tetraspanins and Cell Cycle Regulation (poster, May 2025)
- World Congress of Endometriosis, Australia – In Silico Study of Endometrium Reveals the Role of Complement Coagulation Crosstalk in Endometriosis and Highlights the Potential of JAK Inhibitors (poster, May 2025)
- Marie Curie Alumni Association Annual Conference, Poland – The Potential of JAK Inhibitors: Ruxolitinib and Tofacitinib in Endometriosis Treatment (talk, Mar 2025)
Wykłady
- International Women’s Day Forum, University of Cambridge – Leveraging Transcriptomic Datasets for Diagnostic and Therapeutic Advances in Endometriosis (Mar 2026)
- AI and Reproduction Workshop, Womb to World / ai@cam – Can Artificial Intelligence Advance Research in Endometriosis and Ovarian Cancer? (Nov 2025)
- The Alan Turing Institute, AI in Women’s Health Group – Improving Diagnosis of Endometriosis: Molecular and Imaging Biomarkers (June 2024)“The relationship between hormone receptor status and metabolism in breast cancer”, CRUK Cambridge, Feb 2024
- Cambridge Reproduction Summer School – New Imaging Strategies to Improve Diagnosis of Endometriosis (Sep, 2023)